On Wednesday, iKang Healthcare Group Inc (ADR) (NASDAQ:KANG)’s shares declined -1.76% to $16.75.
iKang Healthcare Group, Inc. (KANG), China’s largest private preventive healthcare services provider, recently declared that it has formed a joint venture (“Joint Venture”) with former shareholders of Yinchuan Ciming Clinic Co., Ltd. (“Yinchuan Ciming” or “Yinchuan Ciming Medical Center”). Yinchuan Ciming was franchised from Ciming Checkup Group, the third largest private preventive healthcare services provider in China. iKang now owns 70% equity in the Joint Venture, which itself controls 100% ownership of Yinchuan Ciming. Yinchuan Ciming is the largest private preventive healthcare services provider in Yinchuan and has been renamed to Yinchuan iKang. Yinchuan is the capital city of Ningxia Hui Autonomous Region in China.
This acquisition has particular planned significance for iKang as it will act as a beacon to attract more high-quality Ciming franchises to join iKang. Yinchuan Ciming Medical Center ranked among the top Ciming franchises in 2014 in terms of revenue. In November 2014, iKang attained three medical centers that were franchised from Ciming Checkup Group in the city of Shenyang. This acquisition marks the second time that a Ciming franchisee has turned down Ciming Checkup Group and others in favour of iKang.
iKang Healthcare Group, Inc., together with its auxiliaries, provides preventive healthcare solutions in the People’s Republic of China. The company offers a range of medical examinations, which comprise internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.
Entergy Corporation (NYSE:ETR)’s shares gained 0.19% to $70.11.
Entergy Corporation (ETR) declared that Robert Hall III has been named vice president, federal governmental affairs. Based in Entergy’s Washington, D.C., office, Hall’s responsibilities comprise developing and implementing the company’s stakeholder engagement strategies with elected officials and key policymakers.
Hall comes to Entergy from General Electric, where he served as the lead U.S. government affairs advocate for the company’s multiple energy technologies through his role as executive counsel. During his nearly 30 year career in Washington, Hall also worked at Dutko Worldwide as a senior vice president, as managing director of global government affairs at INVISTA and at Koch Industries as director, government affairs. He began his career as legislative counsel in the office of Sen. Sam Nunn.
Hall received his bachelor’s degree in political science from the University of Georgia and his Juris Doctor from the University of Georgia School of Law. He is a member of the State Bar of Georgia. Hall will report to Kimberly Despeaux, senior vice president, federal policy, regulatory and governmental affairs.
Entergy Corporation, together with its auxiliaries, engages in the electric power production and retail electric distribution operations in the United States. It operates in two segments, Utility and Entergy Wholesale Commodities. The Utility segment generates, transmits, distributes, and sells electric power in portions of Arkansas, Mississippi, Texas, and Louisiana, counting the City of New Orleans; and distributes natural gas.
At the end of Wednesday’s trade, Cepheid (NASDAQ:CPHD)‘s shares dipped -1.10% to $55.71.
Cepheid (CPHD) unveiled the GeneXpert® Omni, a flexible and portable clinical molecular diagnostic system designed to meet the needs of the Point of Care market. At just 9 inches tall, and weighing just 2.2 pounds, the GeneXpert Omni will run the same high quality PCR-based Xpert® cartridges as Cepheid’s existing family of GeneXpert Systems, enabling highly accurate clinical molecular diagnostic tests to be performed in any near-patient testing environment, counting CLIA-waived physician offices, clinics and specialty settings.
Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical market and non-clinical markets. Its systems enable molecular testing for organisms and genetic-based diseases by automating manual laboratory procedures.
Magna International Inc. (USA) (NYSE:MGA), ended its Wednesday’s trading session with 1.36% gain, and closed at $54.53.
Magna International Inc. (MGA) will declare its financial results for the second quarter ended June 30, 2015.
Magna will hold its quarterly conference call on Friday, August 7, 2015 at 8:00 a.m. Eastern Time. The number to use for this call is 1-800-743-9807. Overseas callers should use 1-416-641-6701. Please call in at least 10 minutes proceeding to start time. The conference call will be webcast at www.magna.com, and will be chaired by Don Walker, Chief Executive Officer.
Magna International Inc. develops, manufactures, engineers, supplies, and sells automotive products. It operates through North America, Europe, Asia, and Rest of World segments. The company offers body and chassis systems, and related engineering services; seating systems, counting complete seating systems, seat structures and mechanisms, and foam and trim products; interior components and systems, such as garnish and hard trim, soft trim, instrument panels and consoles, overhead systems, and door panels, in addition to powertrain systems, such as driveline systems, fluid pressure and controls, metal forming solutions, and engineering services and system integration solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
